{"id":"W2028218566","doi":"10.1007/s00520-012-1384-0","title":"Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials","year":2012,"lang":"en","type":"article","venue":"Supportive Care in Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"Bristol-Myers Squibb","keywords":"Ixabepilone; Medicine; Common Terminology Criteria for Adverse Events; Internal medicine; Adverse effect; Peripheral neuropathy; Oncology; Breast cancer; Cancer; Metastatic breast cancer; Surgery; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001836505,0.0001923459,0.0007367295,0.00002306221,0.0001413874,0.00001767893,0.0001681817,0.0001368725,0.002043889],"category_scores_gemma":[0.0005825137,0.0001268888,0.000111685,0.0001400584,0.0002272336,0.0002105291,0.0002700439,0.0003924052,0.000007127055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002395283,"about_ca_system_score_gemma":0.0003124159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001850733,"about_ca_topic_score_gemma":0.002760465,"domain_scores_codex":[0.9975786,0.0006719918,0.0007076935,0.0004140395,0.0001799219,0.0004477358],"domain_scores_gemma":[0.9982056,0.0007602135,0.0002965082,0.0004132498,0.0001196341,0.0002048163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004562459,0.001145064,0.8626052,0.00001943492,0.0006690907,0.0001117823,0.01732881,6.154636e-7,0.001191766,0.000004777687,0.03213094,0.08023012],"study_design_scores_gemma":[0.0504695,0.003069508,0.7639616,0.0001363675,0.001984057,0.00001329738,0.007929701,0.0001696265,0.001606543,0.00002270455,0.170227,0.0004101183],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758562,0.01560963,0.000002873642,0.002100071,0.002034812,0.0007469383,0.003323298,0.00002832075,0.0002978615],"genre_scores_gemma":[0.9913607,0.00268358,0.000009166417,0.002651966,0.001515593,0.000129393,0.001180585,0.00002583488,0.0004431382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1380961,"threshold_uncertainty_score":0.9988684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2929814402350561,"score_gpt":0.5714225348632923,"score_spread":0.2784410946282362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}